Submitted by drupal on Sat, 10/27/2012 - 4:55pm NCT00905372 Solanezumab United States Friday, May 1, 2009 – Sunday, April 1, 2012 1 000 Phase 3 Alzheimer's Disease Eli Lilly & Co. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by drupal on
Submitted by drupal on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.